186 related articles for article (PubMed ID: 23307327)
1. A very rare cancer in Down syndrome: medulloblastoma. Epidemiological data from 13 countries.
Satgé D; Stiller CA; Rutkowski S; von Bueren AO; Lacour B; Sommelet D; Nishi M; Massimino M; Garré ML; Moreno F; Hasle H; Jakab Z; Greenberg M; von der Weid N; Kuehni C; Zurriaga O; Vicente ML; Peris-Bonet R; Benesch M; Vekemans M; Sullivan SG; Rickert C
J Neurooncol; 2013 Mar; 112(1):107-14. PubMed ID: 23307327
[TBL] [Abstract][Full Text] [Related]
2. Incidence and survival of children and young people with central nervous system embryonal tumours in the North of England, 1990-2013.
Fairley L; Picton SV; McNally RJ; Bailey S; McCabe MG; Feltbower RG
Eur J Cancer; 2016 Jul; 61():36-43. PubMed ID: 27151553
[TBL] [Abstract][Full Text] [Related]
3. The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children.
Smoll NR; Drummond KJ
J Clin Neurosci; 2012 Nov; 19(11):1541-4. PubMed ID: 22981874
[TBL] [Abstract][Full Text] [Related]
4. Relative survival of childhood and adult medulloblastomas and primitive neuroectodermal tumors (PNETs).
Smoll NR
Cancer; 2012 Mar; 118(5):1313-22. PubMed ID: 21837678
[TBL] [Abstract][Full Text] [Related]
5. [Epidemiology and pathology of brain tumors in childhood].
Giordana MT
Minerva Med; 1984 Jun; 75(24):1401-6. PubMed ID: 6330617
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas.
Phi JH; Kim JH; Eun KM; Wang KC; Park KH; Choi SA; Kim YY; Park SH; Cho BK; Kim SK
J Neurosurg Pediatr; 2010 Jun; 5(6):608-14. PubMed ID: 20515335
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC study.
Le Teuff G; Castaneda-Heredia A; Dufour C; Jaspan T; Calmon R; Devos A; McHugh K; Leblond P; Frappaz D; Aerts I; Zwaan CM; Ducassou S; Chastagner P; Verschuur A; Corradini N; Casanova M; Rubie H; Riccardi R; Le Deley MC; Vassal G; Geoerger B;
Pediatr Blood Cancer; 2020 Jan; 67(1):e28032. PubMed ID: 31595663
[TBL] [Abstract][Full Text] [Related]
8. Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med.
Katsetos CD; Herman MM; Krishna L; Vender JR; Vinores SA; Agamanolis DP; Schiffer D; Burger PC; Urich H
Arch Pathol Lab Med; 1995 Aug; 119(8):734-43. PubMed ID: 7646332
[TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma incidence has not changed over time: a CBTRUS study.
Partap S; Curran EK; Propp JM; Le GM; Sainani KL; Fisher PG
J Pediatr Hematol Oncol; 2009 Dec; 31(12):970-1. PubMed ID: 19887963
[TBL] [Abstract][Full Text] [Related]
10.
Beckmann PJ; Larson JD; Larsson AT; Ostergaard JP; Wagner S; Rahrmann EP; Shamsan GA; Otto GM; Williams RL; Wang J; Lee C; Tschida BR; Das P; Dubuc AM; Moriarity BS; Picard D; Wu X; Rodriguez FJ; Rosemarie Q; Krebs RD; Molan AM; Demer AM; Frees MM; Rizzardi AE; Schmechel SC; Eberhart CG; Jenkins RB; Wechsler-Reya RJ; Odde DJ; Huang A; Taylor MD; Sarver AL; Largaespada DA
Cancer Res; 2019 Mar; 79(5):905-917. PubMed ID: 30674530
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of adult medulloblastoma.
Giordana MT; Schiffer P; Lanotte M; Girardi P; Chio A
Int J Cancer; 1999 Mar; 80(5):689-92. PubMed ID: 10048968
[TBL] [Abstract][Full Text] [Related]
12. SHH desmoplastic/nodular medulloblastoma and Gorlin syndrome in the setting of Down syndrome: case report, molecular profiling, and review of the literature.
Mangum R; Varga E; Boué DR; Capper D; Benesch M; Leonard J; Osorio DS; Pierson CR; Zumberge N; Sahm F; Schrimpf D; Pfister SM; Finlay JL
Childs Nerv Syst; 2016 Dec; 32(12):2439-2446. PubMed ID: 27444290
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of Outcomes by Treatment Regimen and Histology in Central Nervous System Primary Embryonal Tumors.
Bhimani AD; Ryoo JS; Reddy AK; Denyer S; McGuire LS; Alonso M; Mehta AI
World Neurosurg; 2020 Sep; 141():e289-e306. PubMed ID: 32434022
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma.
Miller S; Rogers HA; Lyon P; Rand V; Adamowicz-Brice M; Clifford SC; Hayden JT; Dyer S; Pfister S; Korshunov A; Brundler MA; Lowe J; Coyle B; Grundy RG
Neuro Oncol; 2011 Aug; 13(8):866-79. PubMed ID: 21798848
[TBL] [Abstract][Full Text] [Related]
15. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group.
Robertson PL; Muraszko KM; Holmes EJ; Sposto R; Packer RJ; Gajjar A; Dias MS; Allen JC;
J Neurosurg; 2006 Dec; 105(6 Suppl):444-51. PubMed ID: 17184075
[TBL] [Abstract][Full Text] [Related]
16. [Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranial germ cell tumors in childhood].
Kortmann RD; Kühl J; Timmermann B; Calaminus G; Dieckmann K; Wurm R; Sörensen N; Urban C; Göbel U; Bamberg M
Strahlenther Onkol; 2001 Sep; 177(9):447-61. PubMed ID: 11591018
[TBL] [Abstract][Full Text] [Related]
17. Intense p53 staining is a valuable prognostic indicator for poor prognosis in medulloblastoma/central nervous system primitive neuroectodermal tumors.
Woodburn RT; Azzarelli B; Montebello JF; Goss IE
J Neurooncol; 2001 Mar; 52(1):57-62. PubMed ID: 11451203
[TBL] [Abstract][Full Text] [Related]
18. A lack of neuroblastoma in Down syndrome: a study from 11 European countries.
Satgé D; Sasco AJ; Carlsen NL; Stiller CA; Rubie H; Hero B; de Bernardi B; de Kraker J; Coze C; Kogner P; Langmark F; Hakvoort-Cammel FG; Beck D; von der Weid N; Parkes S; Hartmann O; Lippens RJ; Kamps WA; Sommelet D
Cancer Res; 1998 Feb; 58(3):448-52. PubMed ID: 9458088
[TBL] [Abstract][Full Text] [Related]
19. Cerebellar tumors.
Guerreiro Stucklin AS; Grotzer MA
Handb Clin Neurol; 2018; 155():289-299. PubMed ID: 29891066
[TBL] [Abstract][Full Text] [Related]
20. Foxr2 promotes formation of CNS-embryonal tumors in a Trp53-deficient background.
Poh B; Koso H; Momota H; Komori T; Suzuki Y; Yoshida N; Ino Y; Todo T; Watanabe S
Neuro Oncol; 2019 Aug; 21(8):993-1004. PubMed ID: 30976792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
